Skip to main content

Advertisement

Log in

Lysosome regulation of microglia in Alzheimer’s disease via TFEB–vacuolar ATPase

  • Research Briefing
  • Published:

From Nature Neuroscience

View current issue Submit your manuscript

We show that genetic disruption of TFEB- and vacuolar ATPase-mediated lysosomal signaling leads to increased tau pathology and defective microglia activation. Our findings demonstrate an essential role of the lysosome in regulating microglia activity in tauopathy and Alzheimer’s disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: TFEB–v-ATPase signaling in lysosome homeostasis.

References

  1. Colacurcio, D. J. & Nixon, R. A. Disorders of lysosomal acidification–the emerging role of v-ATPase in aging and neurodegenerative disease. Ageing Res. Rev. 32, 75–88 (2016). This article summarizes evidence that links dysfunction of the v-ATPase complex to neurodegenerative diseases.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Martini-Stoica, H. et al. The autophagy-lysosomal pathway in neurodegeneration: a TFEB perspective. Trends Neurosci. 39, 221–234 (2016). This review discusses the regulation of TFEB in the autophagy–lysosomal pathway and its function in neurodegenerative diseases.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Leng, F. & Edison, P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat. Rev. Neurol. 17, 157–172 (2021). This review discusses the effect of neuroinflammation in the disease trajectory in Alzheimer’s disease, with a focus on microglia.

    Article  PubMed  Google Scholar 

  4. Ballabio, A. & Bonifacino, J. S. Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat. Rev. Mol. Cell Biol. 21, 101–118 (2020). This article reviews recent discoveries that highlight the lysosome as a regulatory hub for cellular and organismal homeostasis.

    Article  CAS  PubMed  Google Scholar 

  5. Ulland, T. K. et al. TREM2 maintains microglial metabolic fitness in Alzheimer’s disease. Cell 170, 649–663.e613 (2017). This paper shows that TREM2 regulates microglial metabolism and bioenergics via mTOR signaling and that TREM2 loss-of-function-induced metabolic defects can be rescued by boosting ATP levels.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Wang, B. et al. TFEB–vacuolar ATPase signaling regulates lysosomal function and microglial activation in tauopathy. Nat. Neurosci. https://doi.org/10.1038/s41593-023-01494-2 (2023).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lysosome regulation of microglia in Alzheimer’s disease via TFEB–vacuolar ATPase. Nat Neurosci 27, 13–14 (2024). https://doi.org/10.1038/s41593-023-01495-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41593-023-01495-1

  • Springer Nature America, Inc.

Navigation